BC
Boston Children's Hospital / Dana-Farber Cancer Institute at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Boston Children's Hospital / Dana-Farber Cancer Institute brings 2 presentations to AMP 2026 in Seattle. Its programme centres on molecular diagnostics for paediatric and young adult cancers, with a second strand on what members need from AMP in clinical practice. The cancer work follows tumour profiling through to the decisions it changes in the clinic.
| Organization | AMP 2026 Attendance |
|---|---|
BC Boston Children's Hospital / Dana-Farber Cancer Institute Boston, MA | |
Paediatric hospital and cancer institute in Boston that jointly run childhood cancer care and molecular diagnostics. | Talk Fri, Nov 13 10:15am–11:00am From Profiling to Clinical Impact: Advancing Molecular Diagnostics for Pediatric and AYA Cancers Molecular profiling for children and young adults with cancer: what has improved, what blocks access, and how results reach patients. Workshop Fri, Nov 13 3:00pm–3:30pm The Practice Pulse: Identifying Where Members Need AMP Most (An AMP Clinical Practice Committee Open Forum) Where clinical practice gaps sit today, with member input steering which problems the committee takes on next. |
Instantly find 20 buyers from Boston Children's Hospital / Dana-Farber Cancer Institute
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction